Two Sigma Securities, LLC Incyte Corp Call Options Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$85.07 - $109.69 $433,856 - $559,419
-5,100 Closed
0 $0
Q2 2020

Sep 10, 2020
BUY
$74.18 - $108.93 $378,318 - $555,543
5,100 New
5,100 $530,000
Q1 2020

May 15, 2020
SELL
$63.18 - $85.97 $726,570 - $988,655
-11,500 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$73.04 - $95.72 $839,960 - $1.1 Million
11,500 New
11,500 $1 Million

Others Institutions Holding INCY

# of Institutions
652
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email